Skip to main content
Pharmacist reviewing a structured, synthetic medication-review case.

Use Cases

Five synthetic pharmacist-review scenarios.

These scenarios shape the workflow design and the guided demonstration. Every case is synthetic and non-identifiable — none of it is patient data.

How to read these scenarios

Each entry shows the same four things.

A review objective, what the demonstration illustrates about the workflow, a build-status badge and a reminder that the content is synthetic.

Scenario library

Each scenario exercises a different part of the review workflow.

One scenario deliberately withholds a review summary to demonstrate the abstention path when information is insufficient.

RD-CASE-001

New statin-review case

Review objective

Organize a first structured review of a newly opened statin-related case.

What this demonstration shows

  • Guided review intake
  • Guideline copilot
  • AI-assisted draft
  • Human approval gate

Synthetic demonstration case — not patient data.

Open this synthetic case
Editorial illustration for the New statin-review case synthetic scenario.

RD-CASE-002

Inadequate lipid-control review

Review objective

Structure a review where the case record describes control as not yet at the documented target context.

What this demonstration shows

  • Structured review
  • Why This Result
  • AI-assisted draft
  • Trend view

Synthetic demonstration case — not patient data.

Open this synthetic case
Editorial illustration for the Inadequate lipid-control review synthetic scenario.

RD-CASE-003

Possible statin-intolerance / SAMS review

Review objective

Structure a review where the case record contains reported tolerance concerns for pharmacist attention.

What this demonstration shows

  • Structured review
  • Guideline copilot
  • Why This Result
  • Human approval gate

Synthetic demonstration case — not patient data.

Open this synthetic case
Editorial illustration for the Possible statin-intolerance / SAMS review synthetic scenario.

RD-CASE-004

Medication-review / polypharmacy context

Review objective

Structure a broader medication review where the case record contains an extended co-medication list.

What this demonstration shows

  • Guided review intake
  • Guideline copilot
  • Editable report export
  • Audit history

Synthetic demonstration case — not patient data.

Open this synthetic case
Editorial illustration for the Medication-review / polypharmacy context synthetic scenario.

RD-CASE-005

Incomplete-data / abstention case

Review objective

Illustrate the abstention path when a case record does not contain enough structured information.

What this demonstration shows

  • Missing-information detection
  • Confidence and abstention
  • Audit history

Synthetic demonstration case — not patient data.

Open this synthetic case
Editorial illustration for the Incomplete-data / abstention case synthetic scenario.

Synthetic data policy

Synthetic cases support workflow design, testing and demonstration. They do not establish clinical or Canadian validation.

Try it yourself

Step through a guided synthetic review.